Your browser doesn't support javascript.
loading
Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study.
van Asseldonk, Edwin J P; Stienstra, Rinke; Koenen, Tim B; Joosten, Leo A B; Netea, Mihai G; Tack, Cees J.
Affiliation
  • van Asseldonk EJ; Department of Internal Medicine, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands. e.vanasseldonk@aig.umcn.nl
J Clin Endocrinol Metab ; 96(7): 2119-26, 2011 Jul.
Article in En | MEDLINE | ID: mdl-21508140

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Insulin Resistance / Metabolic Syndrome / Interleukin 1 Receptor Antagonist Protein / Hypoglycemic Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2011 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Insulin Resistance / Metabolic Syndrome / Interleukin 1 Receptor Antagonist Protein / Hypoglycemic Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2011 Document type: Article Affiliation country: Netherlands